Zovegalisib Plus Fulvestrant Yields Durable Efficacy in PIK3CA+, HR+/HER2– Advanced Breast Cancer – OncLive March 7, 2026 by live-feeds Zovegalisib Plus Fulvestrant Yields Durable Efficacy in PIK3CA+, HR+/HER2– Advanced Breast Cancer OncLive Source link Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Related Related posts: Understanding Molecular Changes in High-Grade Serous Ovarian Cancer from Fallopian Tube Precursors Texas Measles Outbreak: 22 Children, 2 Adults Infected. Sudden Cardiac Death: The Hidden Risk of Undiagnosed Cardiovascular Disease 7-Day Anti-Inflammatory, High-Protein Meal Plan for Spring